Table 2. Performance of the Final pdCSM-Cancer Regression Models on Cross-Validation and Blind Test Sets.

tissue	cell lines	Pearson (CV)	Pearson (blind test)
CNS	SF-268	0.66	0.59
	SF-295	0.68	0.59
	SF-539	0.66	0.59
	SNB-19	0.66	0.61
	SNB-75	0.63	0.59
	SNB-78	0.61	0.52
	U251	0.69	0.63
	XF-498	0.60	0.51
breast	BT-549	0.65	0.56
	HS-578 T	0.64	0.54
	MCF7	0.69	0.59
	MDA-MB-231_ATCC	0.68	0.58
	MDA-MB-468	0.58	0.49
	T-47D	0.64	0.56
colon	COLO-205	0.67	0.58
	DLD-1	0.66	0.59
	HCC-2998	0.63	0.63
	HCT-116	0.69	0.61
	HCT-15	0.63	0.56
	HT29	0.67	0.65
	KM12	0.66	0.59
	KM20L2	0.62	0.53
	SW-620	0.69	0.59
leukemia	CCRF-CEM	0.65	0.59
	HL-60 TB	0.63	0.56
	K-562	0.66	0.57
	MOLT-4	0.67	0.59
	P388_ADR	0.69	0.67
	P388	0.74	0.65
	RPMI-8226	0.63	0.59
	SR	0.63	0.62
ovarian	IGROV1	0.66	0.57
	NCI_ADR-RES	0.65	0.56
	OVCAR-3	0.67	0.58
	OVCAR-4	0.63	0.62
	OVCAR-5	0.64	0.54
	OVCAR-8	0.68	0.59
	SK-OV-3	0.65	0.57
prostate	DU-145	0.67	0.58
	PC-3	0.69	0.59
renal	786-0	0.65	0.56
	A498	0.64	0.63
	ACHN	0.68	0.59
	CAKI-1	0.65	0.56
	RXF-393	0.65	0.56
	RXF-631	0.66	0.63
	SN12C	0.65	0.59
	SN12K1	0.74	0.65
	TK-10	0.64	0.61
	UO-31	0.65	0.55
non-small cell lung	A549_ATCC	0.68	0.58
	EKVX	0.62	0.53
	HOP-18	0.54	0.48
	HOP-62	0.65	0.59
	HOP-92	0.60	0.57
	LXFL-529	0.67	0.59
	NCI-H226	0.64	0.54
	NCI-H23	0.69	0.59
	NCI-H322M	0.64	0.67
	NCI-H460	0.69	0.63
	NCI-H522	0.67	0.57
small cell lung	DMS-114	0.67	0.58
	DMS-273	0.58	0.48
melanoma	LOX-IMVI	0.67	0.59
	M14	0.66	0.58
	M19-MEL	0.66	0.59
	MALME-3 M	0.64	0.59
	MDA-MB-435	0.68	0.59
	MDA-N	0.66	0.61
	SK-MEL-28	0.66	0.59
	SK-MEL-2	0.65	0.56
	SK-MEL-5	0.66	0.64
	UACC-257	0.65	0.59
	UACC-62	0.67	0.59